Shares of Novo Nordisk rose over 2% in premarket trading. Novo Nordisk said on Monday that it was launching a new offer for self-paying type 2 diabetes patients in the U.S. to access Ozempic for $499 per month.

Palantir stock fell 0.7% in premarket trading. According to Tyler Radke, a senior Citigroup equity analyst, Palantir’s lofty valuations are difficult to justify despite its “outstanding Q2 results.”

The stock has declined 15% over the past week, after Andrew Left’s Citron Research revealed a short position in the company.

Yet, Radke warns that the company’s valuation is still too rich, “this stock, even despite its slide, is still trading at around 70 times forward revenue,” he notes, adding that it was on the high end of the broader market’s valuation range, while speaking on CNBC’s ‘Squawk Box’ on Thursday.

Zoom raised its annual revenue and profit forecasts on Thursday, banking on hybrid work trends and the integration of artificial intelligence technology into its products, sending its shares up over 5% in premarket trading.

Crypto shares gained in premarket trading. SharpLink Gaming, BitMine, Upexi, DeFi Devi up over 3%; Circle up 2%.

Rare earth shares jumped in premarket trading. USA Rare Earth up about 4%; The Metals up 2%.